Aleksander Mendyk
About
In The Last Decade
Aleksander Mendyk
83 papers receiving 961 citations
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 297
- Molecular Biology 178
- Biomedical Engineering 165
- Computational Theory and Mathematics 141
- Materials Chemistry 117
Countries citing papers authored by Aleksander Mendyk
This map shows the geographic impact of Aleksander Mendyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksander Mendyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksander Mendyk more than expected).
Fields of papers citing papers by Aleksander Mendyk
This network shows the impact of papers produced by Aleksander Mendyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksander Mendyk. The network helps show where Aleksander Mendyk may publish in the future.
Co-authorship network of co-authors of Aleksander Mendyk
This figure shows the co-authorship network connecting the top 25 collaborators of Aleksander Mendyk. A scholar is included among the top collaborators of Aleksander Mendyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksander Mendyk. Aleksander Mendyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 9 | |
| 10 | 9 | |
| 11 | 1 | |
| 12 | 8 | |
| 13 | 42 | |
| 14 | 17 | |
| 15 | ToxComp ∔ In vitro-in vivo extrapolation system for drug proarrhythmic potency assessment | 3 |
| 16 | Modeling and simulation approach for assessing proarrhythmic potency of the non-cardiological drugs | 1 |
| 17 | In silico prediction of the drug overdose consequences at the heart electrophysiology level | 1 |
| 18 | E-learning in pharmaceutical continuing education in Poland | 2 |
| 19 | Randomforest based assessment of the hERG channel inhibition potential for the early drug cardiotoxicity testing | 3 |
| 20 | Artificial Neural Networks (ANNs) as a tool of estimating relation between parameters of anti-oxidative ability and nutritional ingredients in the diet of pregnant women | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.